Abstract:The VHL protein (pVHL) functions as a tumor suppressor by regulating the degradation or activation of protein substrates such as HIF1α and Akt. In human cancers harboring wild-type VHL, the aberrant downregulation of pVHL is frequently detected and critically contributes to tumor progression. However, the underlying mechanism by which the stability of pVHL is deregulated in these cancers remains elusive. Here, we identify cyclin-dependent kinase 1 (CDK1) and peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (PIN1) as two previously uncharacterized regulators of pVHL in multiple types of human cancers harboring wild-type VHL including triple-negative breast cancer (TNBC). PIN1 and CDK1 cooperatively modulate the protein turnover of pVHL, thereby conferring tumor growth, chemotherapeutic resistance and metastasis both in vitro and in vivo. Mechanistically, CDK1 directly phosphorylates pVHL at Ser80, which primes the recognition of pVHL by PIN1. PIN1 then binds to phosphorylated pVHL and facilitates the recruitment of the E3 ligase WSB1, therefore targeting pVHL for ubiquitination and degradation. Furthermore, the genetic ablation or pharmacological inhibition of CDK1 by RO-3306 and PIN1 by all-trans retinoic acid (ATRA), the standard care for Acute Promyelocytic Leukemia could markedly suppress tumor growth, metastasis and sensitize cancer cells to chemotherapeutic drugs in a pVHL dependent manner. The histological analyses show that PIN1 and CDK1 are highly expressed in TNBC samples, which negatively correlate with the expression of pVHL. Taken together, our findings reveal the previous unrecognized tumor-promoting function of CDK1/PIN1 axis through destabilizing pVHL and provide the preclinical evidence that targeting CDK1/PIN1 is an appealing strategy in the treatment of multiple cancers with wild-type VHL.

VBP1 modulates Wnt/β-catenin signaling by mediating the stability of the transcription factors TCF/LEFs

pVHL regulates protein stability of TCF/LEF transcription factor family via ubiquitin-independent proteasomal degradation

Protein Phosphatase-1 Modulates the Function of Pax-6, a Transcription Factor Controlling Brain and Eye Development

VBP1 negatively regulates CHIP and selectively inhibits the activity of hypoxia-inducible factor (HIF)-1α but not HIF-2α

WSB1 Promotes Tumor Metastasis by Inducing Pvhl Degradation

PIN1 and CDK1 Cooperatively Govern Pvhl Stability and Suppressive Functions

TCTP Increases Stability of Hypoxia‐inducible Factor 1α by Interaction with and Degradation of the Tumour Suppressor VHL

Β-Trcp Couples Β-Catenin Phosphorylation-Degradation and Regulates Xenopus Axis Formation

Fas-associated factor 1 antagonizes Wnt signaling by promoting β-catenin degradation.

VprBP Mitigates TGF-β and Activin Signaling by Promoting Smurf1-mediated Type I Receptor Degradation.

ZEB1 and TCF4 Reciprocally Modulate Their Transcriptional Activities to Regulate Wnt Target Gene Expression

LEF1 enhances {beta}-catenin transactivation through IDR-dependent liquid-liquid phase separation

Pre-B-Cell Leukemia Transcription Factor 1 Regulates Expression of Valosin-Containing Protein, a Gene Involved in Cancer Growth

Eaf1 and Eaf2 Negatively Regulate Canonical Wnt/β-catenin Signaling.

VGLL4 Targets a TCF4–TEAD4 Complex to Coregulate Wnt and Hippo Signalling in Colorectal Cancer

The planar cell polarity protein VANG-1/Vangl negatively regulates Wnt/β-catenin signaling through a Dvl dependent mechanism

VHL suppresses UBE3B-mediated breast tumor growth and metastasis

ZBP1 (DAI/DLM-1) promotes osteogenic differentiation while inhibiting adipogenic differentiation in mesenchymal stem cells through a positive feedback loop of Wnt/β-catenin signaling

Identification Of The Wnt Signaling Activator Leucine-Rich Repeat In Flightless Interaction Protein 2 By A Genome-Wide Functional Analysis

Feedback regulation between ZBP1 and ß-catenin mRNAs in breast cancer cells

LEF1 enhances -catenin transactivation through IDR-dependent liquid-liquid phase separation